| Sample | Title | Value | Rank |
|---|
| GSM303966 | SLE-7 #4 @12wks, asymptomatic (-2077090517) | 21.0325 | 36 |
| GSM303972 | SLE-7 #3 @12wks, asymptomatic (-2077090523) | 25.803 | 39 |
| GSM303986 | SLE-7 #2 @12wks, asymptomatic (-2077090529) | 23.1822 | 37 |
| GSM303991 | SLE-7 #1 @12wks, asymptomatic (-2077090535) | 27.0381 | 39 |
| GSM303961 | SLE-7 #1 @36wks, asymptomatic on treatment with sirolimus (-2101366109) | 50.3894 | 52 |
| GSM303979 | SLE-7 #3 @36wks, asymptomatic on treatment with sirolimus (-2101365196) | 34.426 | 41 |
| GSM303985 | SLE-7 #2 @36wks, asymptomatic on treatment with sirolimus (-2101365652) | 33.2952 | 43 |
| GSM303971 | SLE-7 #2 @36wks, diseased/symptomatic (-2101366115) | 52.163 | 54 |
| GSM303973 | SLE-7 #1 @36wks, diseased/symptomatic (-2101366147) | 38.6987 | 46 |
| GSM303980 | SLE-7 #3 @36wks, diseased/symptomatic (-2102085829) | 49.0409 | 50 |
| GSM303962 | SLE-7 #3 @42wks, asymptomatic on treatment with sirolimus (-2101365164) | 36.756 | 44 |
| GSM303978 | SLE-7 #2 @42wks, asymptomatic on treatment with sirolimus (-2102085846) | 39.1132 | 45 |
| GSM303982 | SLE-7 #1 @42wks, asymptomatic on treatment with sirolimus (-2101365170) | 44.0618 | 47 |
| GSM303965 | SLE-7 #2 @42wks, diseased/symptomatic (-2102085823) | 65.7108 | 57 |
| GSM303968 | SLE-7 #1 @42wks, diseased/symptomatic (-2101365185) | 32.502 | 43 |
| GSM303981 | SLE-7 #3 @42wks, diseased/symptomatic (-2101365176) | 57.4793 | 56 |